CDSCO (India)
NOTICE
WHO Alert on falsified DEFITELIO (Defibrotide) 80 mg/ml concentrate for solution for infusion, B. No. 24GC01A, Exp date 04/2027, Mfg by: Patheon, II Trav. sx Via Morolense, 5, 03013 Ferentino (FR) Italy and Marketing authorisation holder: Gentium S.r.l, Piazza XX Settembre, 2, 22079 Villa Guardia (Como) Italy and identified in India
Published: 10/26/2026Detected: 10/26/2026
Summary preview
Notifies that WHO has issued an alert regarding falsified DEFITELIO (defibrotide) 80 mg/mL concentrate for solution for infusion, identified in India.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from INDIA CDSCO.
More from CDSCO (India)
- Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics10/26/2026
- List of Ethics Committees cancelled by CLA10/19/2026
- Clarification regarding requirement of Export NOC for already approved r-DNA products.10/14/2026
- 2026.10.13 S.O. 5617(E), Notification of Government Analysts for veterinary vaccines at CCSNIAH, Baghpat10/13/2026
- S.O. 5617(E), Notification of Government Analysts for veterinary vaccines at CCSNIAH, Baghpat10/13/2026